NCT01378520View on ClinicalTrials.gov

Effect of Ketoconazole on Breathlessness

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

ketoconazole

600 mg capsule oral once

DRUG

inert powder

oral once

Trial Locations (1)

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01378520 - Effect of Ketoconazole on Breathlessness | Biotech Hunter | Biotech Hunter